Format

Send to

Choose Destination
Front Neurol. 2016 Sep 30;7:167. eCollection 2016.

Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine.

Author information

1
Maastricht University , Maastricht , Netherlands.

KEYWORDS:

Alzheimer; actelylcholine; cognition enhancer; deficit model; memory

Supplemental Content

Full text links

Icon for Frontiers Media SA Icon for PubMed Central
Loading ...
Support Center